31 results
Atrial Fibrillation Overview

Symptoms:
Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

1. Why?
Cardiac:
• Valvular heart disease
•
Atrial Fibrillation ... intolerance, chest pain, near-syncope ... Noncardiac: • Pulmonary ... #Fibrillation #Cardiology ... #Management #Algorithm
Multifocal Atrial Tachycardia (MAT)
• At least 3 different P wave morphologies: 
• Rate 100-180
• Irregular 
Etiology
Multifocal Atrial ... • Hypoxia • Pulmonary ... hypertension Management ... #Multifocal #Atrial ... Tachycardia #MAT #Cardiology
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
flutter, ectopic atrial ... with caution in pulmonary ... with caution in pulmonary ... Tachycardia #Treatment #management ... #cardiology #algorithm
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Ejection Fraction: Management ... relevant Maintain atrial ... sinus rhythm in atrial ... hypertension, pulmonary ... #Cardiology #HFpEF
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Atrial Fibrillation ... intolerance, chest pain, near-syncope ... Noncardiac: • Pulmonary ... AFib #diagnosis #management ... #cardiology
Adult-Onset Still's Disease
Clinical triad: Fever, Arthralgia/arthritis, Skin rash ± odynophagia
+ Biological inflammation: Increased neutrophils, Hyperferritinemia, decreased
Disease Clinical triad ... hepatitis • Pulmonary ... Disease #diagnosis #management ... #treatment #rheumatology
Susac Syndrome - Clinical Triad
 - Central nervous system dysfunction
 - Branch retinal artery occlusion
 -
Syndrome - Clinical Triad ... disease flares - 2-year ... SusacSyndrome #Triad ... #Diagnosis #Management ... #Rheumatology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
randomized controlled trial ... thrombosis; PE = pulmonary ... Anticoagulation #Management ... #Hematology #Oncology
Treatment of giant cell arteritis (GCA)

1st Line Strategy - GC 0.7 mg/kg/day, except for:
 • Aortitis
discuss therapeutic trials ... or SC for > 1 year ... weekly SC for > 1 year ... GCA #Treatment #Management ... #Indications #rheumatology
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
Cardiogenic Shock - Management ... in cardiogenic pulmonary ... (no B-lines on ultrasound ... #HeartFailure #Cardiology ... #Management